AVAntonio Vilasi

Antonio Vilasi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antonio Vilasi has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vascular Access Surgery Timing

    by Boudewijn D.C. Heggen, Nicholas C. Chesnaye, Friedo W. Dekker, Merel van Diepen, Joris I. Rotmans, Fergus J. Caskey, Claudia Torino, Antonio Vilasi, Maciej Szymczak, Christiane Drechsler, et al.

    Key Points: Only 32% of elderly patients with ESKD in Europe started hemodialysis with a functional fistula that was created on time. Vascular access was created early in 42% and late in 26% of patients, exposing these patients to unused fistulas or catheter dependency. Eventually, 90% of all patients after fistula creation started hemodialysis within the mean follow-up period of 30 months. Background: Timing vascular access creation for older patients with ESKD is challenging. Autologous arteriovenous fistulas (AVF) are often created too early, leading to unused fistulas, or too late, necessitating central venous catheters (CVC). This study reports on vascular access creation in relation to hemodialysis initiation in European practice. Methods: This study is a secondary analysis of the European Quality cohort: a prospective observational study that recruited patients aged ≥65 years with stage 4 or 5 CKD from six European countries. Patients were selected once their eGFR dropped below 15 ml/min per 1.73 m 2 , if they received a vascular access, and had at least 6 months of follow-up. Vascular access timing was categorized into three groups: early (no dialysis within 6 months after AVF creation), on time (dialysis initiated with an AVF within 6 months), and late (hemodialysis initiated with a CVC before or within 6 months after AVF creation). Results: A total of 332 patients from the European Quality cohort were analyzed: 221 patients (67%) received an AVF as first vascular access and 111 patients (33%) a CVC. Among the latter, 53 patients (48%) underwent subsequent AVF creation, whereas for the remaining 58 patients, CVC was considered the intended vascular access strategy. At dialysis initiation, 158 patients (54%) used an AVF, while 136 patients (46%) used a CVC. AVF creation was on time in 88 of 274 patients (32%), early in 114 patients (42%), and late in 72 patients (26%). Despite high rates of early AVF creation, most fistulas were eventually used, as 90% of patients initiated hemodialysis within 3 years. Conclusions: Only 32% of elderly patients with ESKD started hemodialysis with a functional AVF created on time (within the 6-month window), while 42% had early and 26% late creation. Clinical prediction tools are needed to optimize vascular access timing.


  • Symptom burden in dialysis patients: determinants and impact on mortality

    by Sabrina Mezzatesta, Giacomo Fiumara, Federico D’ANtoni, Pasquale Fabio Provenzano, Vincenzo Calabrese, Rocco Tripepi, Melisa Granda, José Manuel Gómez-Pulido, Rosalinda Inguanta, Giuseppe Aiello, et al.

    Background: Symptom burden in chronic kidney disease (CKD) patients has a negative impact on functional status and quality of life. Despite the high prevalence among hemodialysis (HD) patients, symptoms are often underestimated. We investigated the determinants of symptoms and their impact on mortality in a large cohort of HD patients. Methods: We analyzed 1825 HD patients for whom at least one questionnaire about symptoms was available. Machine learning-based algorithms were used to identify longitudinal variables associated with symptoms. Univariate and multivariate Cox regression analyses were used to investigate the association between symptoms and mortality. The additional prognostic value of symptoms was explored by using C-statistics and machine learning classification analyses. Results: Appetite Rating, Non-vascular Nervous System Score and Difficulty Following Diet were the variables most associated with symptoms, both at baseline and in longitudinal analyses. Survival analyses showed an independent association between symptoms and all the considered outcomes (Death, Hazard Ratio [HR]fper 10-unit increase: 0.91, 95% confidence interval [CI] 0.87–0.96, P < 0.001; Cardiovascular hospitalizations, HRper 10-unit increase: 0.89, 95% CI 0.84–0.94, P < 0.001; infectious hospitalizations, HRper 10-unit increase: 0.91, 95% CI 0.87–0.96, P < 0.001). However, classification analyses performed by machine learning showed that adding a symptom score to a base model did not significantly improve the performance of the models. Similarly, the improvement in R2, in discrimination power, and in reclassification capability was almost null. Discussion: In the large dataset of the Hemodialysis (HEMO) trial, we found that, among the analyzed variables, those related to eating habits and previous comorbidities were the most closely associated with the symptoms score, both at baseline and during follow-up. Although symptoms were associated with severe clinical outcomes, their prognostic power was limited. However, considering symptom burden in dialysis patients, strict monitoring of eating habits may help improve quality of life in these patients.


  • Open Access

    Monitoring Risk Factors and Improving Adherence to Therapy in Patients With Chronic Kidney Disease (Smit-CKD Project): Pilot Observational Study

    by Antonio Vilasi, Vincenzo Antonio Panuccio, Salvatore Morante, Antonino Villa, Maria Carmela Versace, Sabrina Mezzatesta, Sergio Mercuri, Rosalinda Inguanta, Giuseppe Aiello, Demetrio Cutrupi, et al.

    Background: Chronic kidney disease is a major public health issue, with about 13% of the general adult population and 30% of the elderly affected. Patients in the last stage of this disease have an almost uniquely high risk of death and cardiovascular events, with reduced adherence to therapy representing an additional risk factor for cardiovascular morbidity and mortality. Considering the increased penetration of mobile phones, a mobile app could educate patients to autonomously monitor cardiorenal risk factors. Objective: With this background in mind, we developed an integrated system of a server and app with the aim of improving self-monitoring of cardiovascular and renal risk factors and adherence to therapy. Methods: The software infrastructure for both the Smit-CKD server and Smit-CKD app was developed using standard web-oriented development methodologies preferring open source tools when available. To make the Smit-CKD app suitable for Android and iOS, platforms that allow the development of a multiplatform app starting from a single source code were used. The integrated system was field tested with the help of 22 participants. User satisfaction and adherence to therapy were measured by questionnaires specifically designed for this study; regular use of the app was measured using the daily reports available on the platform. Results: The Smit-CKD app allows the monitoring of cardiorenal risk factors, such as blood pressure, weight, and blood glucose. Collected data are transmitted in real time to the referring general practitioner. In addition, special reminders improve adherence to the medication regimen. Via the Smit-CKD server, general practitioners can monitor the clinical status of their patients and their adherence to therapy. During the test phase, 73% (16/22) of subjects entered all the required data regularly and sent feedback on drug intake. After 6 months of use, the percentage of regular intake of medications rose from 64% (14/22) to 82% (18/22). Analysis of the evaluation questionnaires showed that both the app and server components were well accepted by the users. Conclusions: Our study demonstrated that a simple mobile app, created to self-monitor modifiable cardiorenal risk factors and adherence to therapy, is well tolerated by patients affected by chronic kidney disease. Further studies are required to clarify if the use of this integrated system will have long-term effects on therapy adherence and if self-monitoring of risk factors will improve clinical outcomes in this population.


  • Physical functioning and mortality in very old patients on dialysis

    by Claudia Torino, Francesco Mattace Raso, Jan L.C.M. van Saase, Vincenzo Panuccio, Rocco Tripepi, Antonio Vilasi, Maurizio Postorino, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali


  • A comparative study of the risk profile of hemodialysis patients in a for profit network and in two regional registries of the Italian Society of Nephrology

    by Maurizio Postorino, Claudia Amato, Elena Mancini, Paola Carioni, Graziella D’arrigo, Attilio Di Benedetto, Fabrizio Cerino, Carmela Marino, Antonio Vilasi, Giovanni Tripepi, et al.

    In 2013, the Italian Society of Nephrology joined forces with Nephrocare-Italy to create a clinical research cohort of patients on file in the data-rich clinical management system (EUCLID) of this organization for the performance of observational studies in the hemodialysis (HD) population. To see whether patients in EUCLID are representative of the HD population in Italy, we set out to compare the whole EUCLID population with patients included in the regional HD registries in Emilia-Romagna (Northern Italy) and in Calabria (Southern Italy), the sole regions in Italy which have systematically collected an enlarged clinical data set allowing comparison with the data-rich EUCLID system. An analysis of prevalent and incident patients in 2010 and 2011 showed that EUCLID patients had a lower prevalence of coronary heart disease, peripheral vascular disease, heart failure, valvular heart disease, liver disease, peptic ulcer and other comorbidities and risk factors and a higher fractional urea clearance (Kt/V) than those in the Emilia Romagna and Calabria registries. Accordingly, survival analysis showed a lower mortality risk in the EUCLID 2010 and 2011 cohorts than in the combined two regional registries in the corresponding years: for 2010, hazard ratio (HR) EUCLID vs. Regional registries: 0.80 [95% confidence interval: 0.71–0.90]; for 2011, HR: 0.76 [0.65–0.90]. However, this difference was nullified by statistical adjustment for the difference in comorbidities and risk factors, indicating that the longer survival in the EUCLID database was attributable to the lower risk profile of patients included in that database. This preliminary analysis sets the stage for future observational studies and indicates that appropriate adjustment for difference in comorbidities and risk factors is needed to generalize to the Italian HD population analyses based on the data-rich EUCLID database.